White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory

Shiuan Chen1, Xiaoqiang Wang1, Desiree Ha1

  • 1Beckman Research Institute, City of Hope.

Research Square
|April 1, 2021
PubMed

Insights

Dietary white button mushroom (WBM) interrupts the expression of TMPRSS2, a key protein for coronavirus entry, and reduces inflammatory cytokines. This suggests WBM as a potential dietary intervention for COVID-19.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Transmembrane protease serine 2 (TMPRSS2) is implicated in severe COVID-19 by facilitating viral entry.
  • Androgen receptor (AR) signaling, particularly dihydrotestosterone (DHT)-induced activation, is linked to TMPRSS2 expression and prostate cancer.
  • Dietary white button mushroom (WBM) has previously shown potential in modulating AR activation and immune cells in prostate cancer models.

Approach:

  • Investigated the effect of WBM on DHT-induced AR-TMPRSS2 expression in relevant organs in C57BL/6 mice.
  • Assessed the impact of WBM on serum pro-inflammatory cytokine levels in the mouse model.
  • Utilized AR antagonistic activity of WBM as a mechanistic link.

Key Points:

  • WBM consumption interrupted DHT-induced AR-TMPRSS2 expression in organs targeted by coronaviruses.
  • WBM intake significantly attenuated serum levels of pro-inflammatory cytokines associated with COVID-19 pathogenesis.
  • The AR antagonistic properties of WBM were identified as the mechanism for interrupting AR-TMPRSS2 expression.

Conclusions:

  • White button mushrooms possess unique properties that can interfere with key pathways in COVID-19.
  • WBM demonstrates potential as a safe, low-cost dietary intervention to mitigate COVID-19 severity.
  • Further research into WBM as a complementary therapeutic strategy for COVID-19 is warranted.

Related Concept Videos